榆次麻将点数算法图
Position: Index > News > News

SYRICI’s Safety Evaluation Center Passed the On-site Inspection of US FDA

2018-07-16

Inspector Dr. Stephen Hansen from US FDA proceeded a five-day long GLP inspection to the National Safety Evaluation Research Center of New Drug (Shenyang) from July 2nd to July 6th. The inspector performed a series of detailed inspections on the research projects, such as organization, stuff, SOP, experimental facility, archive files, quality control system etc.

 

Through the inspections for almost a week, Dr. Hansen was very satisfied with the result and spoke highly of the positive teamwork of the center. He considered that the GLP system of the center conformed to the US FDA GLP regulation demand.

 

The successful passage shows that our lab management and operating level obtains the recognition of US FDA. It’s another milestone since the first OECD GLP authentication in 2012.

 

The center has developed rapidly on new drug preclinical safety evaluation since the CFDA GLP in 2003. Supporting by the national medicine major special projects platform, the center can offer to the enterprises a one-stop service including safety evaluation of traditional Chinese medicine, new drug, biological drug and clinical sample test. The US FDA inspection made the center serve clients preferably.

榆次麻将点数算法图 36o彩票开奖下载 168娱乐app2下载 大地娱乐网投 pk10固定五码计划软件 足球比分直播即时比分 MG摆脱游戏如何加减注 重庆福彩欢乐生肖走势图 时时彩长期盈利的玩家 九五之乐线上娱乐 手机赢钱棋牌游戏名字